首页>
外国专利>
ACTIVATION OF NOVEL ESTROGEN RECEPTOR SUPPORTS NEURONAL VIABILITY AND FUNCTION
ACTIVATION OF NOVEL ESTROGEN RECEPTOR SUPPORTS NEURONAL VIABILITY AND FUNCTION
展开▼
机译:新型雌激素受体的激活支持神经元的活力和功能
展开▼
页面导航
摘要
著录项
相似文献
摘要
Neurological dysfunction is prevented or treated by the administration of ligands that activate the GPR30 receptor. Ligands include, but are not limited to, estrogens and structurally related molecules. In a preferred embodiment, the GPR30 ligand is an orally available drug that can cross into the brain from blood. Of particular interest are ligands that do not activate other estrogen receptors, and therefore do not have the classical estrogenic effects attributable to these receptors.
展开▼